Pregled bibliografske jedinice broj: 389006
Comparison of mometasone furoate 0.1% ointment and betamethasone dipropionate 0, 05% ointment in the treatment of psoriasis vulgaris
Comparison of mometasone furoate 0.1% ointment and betamethasone dipropionate 0, 05% ointment in the treatment of psoriasis vulgaris // Acta dermatovenerologica Croatica, 8 (2000), 223-226 (podatak o recenziji nije dostupan, članak, stručni)
CROSBI ID: 389006 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Comparison of mometasone furoate 0.1% ointment and betamethasone dipropionate 0, 05% ointment in the treatment of psoriasis vulgaris
Autori
Peharda, Vesna ; Gruber, Franjo ; Prpić, Larisa ; Kaštelan, Marija ; Brajac, Ines
Izvornik
Acta dermatovenerologica Croatica (1330-027X) 8
(2000);
223-226
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
Mometasone furoate 0.1% ointment; Betamethasone dipropionate 0; 05% ointment; Psoriasis vulgaris
(mometasone furoate 0.1% ointment; betamethasone dipropionate 0; 05% ointment; psoriasis vulgaris)
Sažetak
A single blind comparison of mometasone furoate ointment 0, 1% and betamethasone dipropionate 0, 05% ointment was carried out in 60 patients with psoriasis vulgaris. Mometasone furoate ointment was applied once daily, and betamethasone ointment twice daily. Mometasone furoate produced good results in 85, 7%, and betamethasone in 85, 1% of evaluable patients (p>0, 05). Skin atrophy was more frequent in patients treated with betamethasone. According to the results obtained, we believe thast mometasone furoate is a valuable steroid in the treatment of psoriasis vulgaris.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka
Profili:
Larisa Prpić Massari
(autor)
Ines Brajac
(autor)
Franjo Gruber
(autor)
Marija Kaštelan
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus